BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 9563487)

  • 41. X chromosome inactivation and microsatellite instability in early and advanced bilateral ovarian carcinomas.
    Park TW; Felix JC; Wright TC
    Cancer Res; 1995 Nov; 55(21):4793-6. PubMed ID: 7585507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The malignant potential of ovarian atypical endometriosis].
    Guo L; Liu T; Lang J
    Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):169-72. PubMed ID: 11866970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.
    Jacobs IJ; Kohler MF; Wiseman RW; Marks JR; Whitaker R; Kerns BA; Humphrey P; Berchuck A; Ponder BA; Bast RC
    J Natl Cancer Inst; 1992 Dec; 84(23):1793-8. PubMed ID: 1433368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endometriosis and the neoplastic process.
    Varma R; Rollason T; Gupta JK; Maher ER
    Reproduction; 2004 Mar; 127(3):293-304. PubMed ID: 15016949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histological classification of ovarian cancer.
    Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
    Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epithelial metaplastic changes in ovarian endometriosis.
    Fukunaga M; Ushigome S
    Mod Pathol; 1998 Aug; 11(8):784-8. PubMed ID: 9720509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer.
    Prowse AH; Manek S; Varma R; Liu J; Godwin AK; Maher ER; Tomlinson IP; Kennedy SH
    Int J Cancer; 2006 Aug; 119(3):556-62. PubMed ID: 16506222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
    Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
    J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endometriosis-associated Ovarian Cancers.
    Anglesio MS; Yong PJ
    Clin Obstet Gynecol; 2017 Dec; 60(4):711-727. PubMed ID: 28990985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histologically benign or low-grade malignant tumors adjacent to high-grade ovarian carcinomas contain molecular characteristics of high-grade carcinomas.
    Zheng J; Wan M; Zweizig S; Velicescu M; Yu MC; Dubeau L
    Cancer Res; 1993 Sep; 53(18):4138-42. PubMed ID: 8364906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium.
    Shenson DL; Gallion HH; Powell DE; Pieretti M
    Cancer; 1995 Aug; 76(4):650-7. PubMed ID: 8625160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovering the Deregulated Molecular Functions Involved in Malignant Transformation of Endometriosis to Endometriosis-Associated Ovarian Carcinoma Using a Data-Driven, Function-Based Analysis.
    Chang CM; Yang YP; Chuang JH; Chuang CM; Lin TW; Wang PH; Yu MH; Chang CC
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: correlation with KRAS mutation and the presence of endometriosis.
    Stewart CJ; Walsh MD; Budgeon CA; Crook ML; Buchanan DB
    Pathology; 2013 Oct; 45(6):559-66. PubMed ID: 24018808
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability.
    Amemiya S; Sekizawa A; Otsuka J; Tachikawa T; Saito H; Okai T
    Int J Gynaecol Obstet; 2004 Sep; 86(3):371-6. PubMed ID: 15325855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel insights on the malignant transformation of endometriosis into ovarian carcinoma.
    Gadducci A; Lanfredini N; Tana R
    Gynecol Endocrinol; 2014 Sep; 30(9):612-7. PubMed ID: 24905724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endometriosis and ovarian cancer: clinical and molecular aspects.
    Pavlidou A; Vlahos NF
    Minerva Endocrinol; 2014 Sep; 39(3):155-65. PubMed ID: 25003226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden.
    Anglesio MS; Bashashati A; Wang YK; Senz J; Ha G; Yang W; Aniba MR; Prentice LM; Farahani H; Li Chang H; Karnezis AN; Marra MA; Yong PJ; Hirst M; Gilks B; Shah SP; Huntsman DG
    J Pathol; 2015 Jun; 236(2):201-9. PubMed ID: 25692284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Endometriosis and endometriosis-related ovarian neoplasms].
    Totev T; Tomov S; Gorchev G
    Akush Ginekol (Sofiia); 2013; 52(6):38-42. PubMed ID: 24501879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Precursor lesions of ovarian epithelial malignancy.
    Feeley KM; Wells M
    Histopathology; 2001 Feb; 38(2):87-95. PubMed ID: 11207821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Ovarian endometriosis, fibroma-thecoma and colonic cancer--accidental combination or regularity?].
    Akush Ginekol (Sofiia); 2009; 48(5):50-5. PubMed ID: 20198800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.